Lonza Group AG | 548.40 / +1.90% |
Date/Time | 04/09 / 17:30 |
Chg. / Chg.(%) | 10.20 / +1.90% |
Bid | 548.40 / 4 |
Ask | 548.40 / 4 |
Open | 542.30 |
Previous Close | 538.20 |
High | 554.60 |
Low | 542.30 |
Volume [CHF] | 11,241,216.70 |
Volume [Units] | 20,440 |
Price fixings | 2013 |
ISIN | CH0013841017 |
Security | LONN/Z |
Exchange | Cboe Europe BXE |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Lang & Schwa.. | 495.100 | ![]() |
|
SIX Swiss Ex.. | 548.40 | ![]() |
267,709 |
London Inter.. | 548.32 | ![]() |
68,741 |
Cboe Europe .. | 549.40 | ![]() |
31,162 |
Cboe Europe .. | 548.40 | ![]() |
20,440 |
Turquoise | 550.00 | ![]() |
20,417 |
Nasdaq Other.. | 597.9900 | ![]() |
313 |
Mexico | 12,477.46 | ![]() |
340 |
TradeGate | 294.000 | 298 | |
Frankfurt | 293.9000 | 63 | |
Düsseldorf | 291.20 | 0 | |
München | 291.30 | 0 | |
Berlin | 296.90 | 0 | |
Hamburg | 291.30 | 0 | |
gettex | 296.100 | ||
Singapore | 79.97 | 500 | |
EUREX | Options |
News
- Altimmune Expands AdCOVID™ Manufacturing Collaboration with Lonza
03/12/2021 / 07:00 - GlobeNewswire - Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy and Other Indications
01/12/2021 / 15:05 - GlobeNewswire - Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager
01/08/2021 / 13:00 - GlobeNewswire - Arbor Biotechnologies and Lonza Enter into Gene Editing Technology Licensing Deal
12/23/2020 / 14:00 - GlobeNewswire - Altimmune Adds Lonza as a Manufacturing Partner for Supply of AdCOVID™ its Single-Dose Intranasal Vaccine Candidate for COVID-19
11/10/2020 / 07:00 - GlobeNewswire